In non-hospitalized high-risk adults with COVID-19, Paxlovid was found to reduce the risk of hospitalization or death by 89% compared to placebo.
An Interview With The Team Leader For The Scientific Discovery Of Pfizer’s COVID-19 Drug, Paxlovid
In non-hospitalized high-risk adults with COVID-19, Paxlovid was found to reduce the risk of hospitalization or death by 89% compared to placebo.